Blood test may spot hidden heart killer
NCT ID NCT06943365
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a specific antibody in the blood can help diagnose and predict the course of a rare, life-threatening heart condition called short-coupled ventricular fibrillation (SCVF). Researchers will test 300 adults with SCVF for these antibodies and study how they affect heart cells. The goal is to develop a simple blood test to identify the condition and guide treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC VENTRICULAR FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amsterdam University Medical Center
ACTIVE_NOT_RECRUITINGAmsterdam, Netherlands
-
Institut universitaire de cardiologie et pneumologie de Québec
RECRUITINGQuébec, Quebec, G1V4G5, Canada
-
Ottawa Heart Center
NOT_YET_RECRUITINGOttawa, Ontario, Canada
-
PHRI
ACTIVE_NOT_RECRUITINGHamilton, Ontario, Canada
-
St-Paul's Hospital - University of British Columbia
NOT_YET_RECRUITINGVancouver, British Columbia, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.